IP Library › Granted Patent US 12,415,026
Granted Patent B2
US 12,415,026 · App. 17/851,480 · Granted Sep 16, 2025

Point of injury device to stabilize intracranial pressure and method of stabilization

Inventors: Ghassan S. Kassab (La Jolla, CA); Ali Dabiri (San Diego, CA)
A61M1/772A61B5/031A61B5/036A61B5/4836A61B5/6852A61M25/0029A61M25/0075A61M27/002A61M39/0247A61M2025/0166A61M2027/004A61M2039/0258A61M2039/0273A61M2039/0276A61M2210/0693
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,415,026
App. No.
17/851,480
Granted
Sep 16, 2025
Kind
B2
Abstract

A minimally invasive system for monitoring and treating high intracranial pressure levels resulting from traumatic brain injury comprises an intravenous access device, an elongate member, a console, and an aspiration and injection catheter. The system is capable of monitoring pressure levels and relocating fluid from the brain to another part of the patient's body to sustain overall constant fluid volume. The method of using the minimally invasive system is also described.

Claims (28)

1. A system to stabilize intracranial pressure, comprising:

an intravenous access device;

an elongate member comprising at least one electrode section, the at least one electrode section having at least one electrode thereon; and

an aspiration and injection catheter having a first end, a second end, and a third end, the aspiration and injection catheter configured so that the first end and the second end can be positioned at least partially within a mammalian body, and further configured so that the third end can operably connect to a suction or injection device.

2. The system of claim 1 , wherein the first end, the second end, and the third end are in fluid communication with each other.

3. The system of claim 1 , further comprising:

one or more valves positioned within the aspiration and injection catheter, the one or more valves designed to direct flow from at least one of the first end, the second end, or the third end, to another of the first end, the second end, or the third end.

4. The system of claim 1 , further comprising:

a first valve and a second valve positioned within the aspiration and injection catheter, each of the first valve and the second valve comprising an open and a closed position.

5. The system of claim 4 , wherein when the first valve is open and the second valve is closed, fluid within the aspiration and injection catheter may travel from the first end to the third end.

6. The system of claim 4 , wherein when the first valve is closed and the second valve is open, fluid within the aspiration and injection catheter may travel from the third end to the second end.

7. The system of claim 1 , wherein the aspiration and injection catheter further comprises a pressure monitor configured to obtain pressure data within the aspiration and injection catheter.

8. The system of claim 1 , wherein the aspiration and injection catheter is configured to connect to the intravenous access device.

9. The system of claim 8 , wherein the aspiration and injection catheter is in fluid communication with the intravenous access device.

10. The system of claim 1 , further comprising:

a console in communication with the elongate member and configured to obtain data from the at least one electrode section of the elongate member.

11. A method to stabilize intracranial pressure of a patient, comprising the steps of:

advancing an elongate member of a system to a target site of a brain of a patient, the system comprising:

an intravenous access device,

the elongate member, wherein the elongate member comprises at least one electrode section, the at least one electrode section having at least one electrode thereon, and

an aspiration and injection catheter having a first end, a second end, and a third end, the aspiration and injection catheter configured so that the first end and the second end can be positioned at least partially within a mammalian body, and further configured so that the third end can operably connect to a suction or injection device;

advancing at least part of the intravenous access device over at least part of the elongate member; and

advancing the aspiration and injection catheter through the intravenous access device such that the first end is at the target site sinus of the brain of the patient, the second end is at a location in the vasculature of the patient and outside the venous sinus, and the third end is exterior of the patient.

12. The method of claim 11 , wherein the elongate member is introduced into the patient via an access site on the patient.

13. The method of claim 12 , wherein the access site is selected from the group consisting of a radial vein, a cephalic vein, a brachial vein, a basilica vein, and a saphenous vein, in an arm of the patient.

14. The method of claim 11 , wherein the elongate member is a conductance guidewire in communication with a console connected thereto, and wherein the step of advancing the elongated member is performed while obtaining conductance information from the at least one electrode section.

15. The method of claim 14 , wherein the conductance information is processed by the console and displayed on the console to facilitate advancement of the conductance guidewire.

16. The method of claim 11 , wherein the intravenous access device is selected from the group consisting of an indwelling catheter, a peripherally inserted central catheter, and a central venous catheter.

Continuity (3)
Continuation 16211031 · Dec 5, 2018
Provisional Application 62594923 · Dec 5, 2017
Related Publication 20220323664A1 · Oct 13, 2022
References Cited (6)
US 5827216A · Igo · 1998 [cited by examiner]
US 11369721B2 · Kassab · 2022 [cited by examiner]
US 20040147871A1 · Burnett · 2004 [cited by examiner]
US 20100022950A1 · Anderson · 2010 [cited by examiner]
US 20170333687A1 · Murphy · 2017 [cited by examiner]
US 20180056050A1 · Degen · 2018 [cited by examiner]